Immediate Impact

1 by Nobel laureates 2 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Beyond genetics: driving cancer with the tumour microenvironment behind the wheel
2024 Standout
2 intermediate papers

Works of Stephen Brincat being referenced

Randomized Phase III Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
2012
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy
2011

Author Peers

Author Last Decade Papers Cites
Stephen Brincat 227 233 193 9 469
A A Sandberg 233 147 266 7 574
Xinbo Liao 182 84 300 9 480
Kuo-Pao Lai 238 154 226 6 492
Gregory Cesarone 136 251 294 11 569
Martin Brower 154 251 161 8 475
Katherine Lewis 126 127 145 6 429
S. Paul Perry 82 115 142 11 476
Jason Kirk 130 121 289 16 477
Ceren Gönen Korkmaz 140 83 225 14 441
D. R. Budman 78 268 257 14 552

All Works

Loading papers...

Rankless by CCL
2026